| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.054 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |